{"id":5567,"date":"2024-12-12T10:25:00","date_gmt":"2024-12-12T10:25:00","guid":{"rendered":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/"},"modified":"2024-12-12T10:25:00","modified_gmt":"2024-12-12T10:25:00","slug":"%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2","status":"publish","type":"post","link":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/","title":{"rendered":"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH)"},"content":{"rendered":"<p><span class=\"legendSpanClass\">\u5317\u4eac<\/span><span class=\"legendSpanClass\">2024\u5e7412\u670812\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; 2024\u5e7412\u67086\u65e5\u81f312\u65e5\uff0c\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a\uff08ASH 2024\uff09\u5728\u7f8e\u56fd\u5723\u5730\u4e9a\u54e5\u76db\u5927\u53ec\u5f00\u3002\u672c\u6b21\u5927\u4f1a\u662f\u5168\u7403\u8840\u6db2\u5b66\u9886\u57df\u6700\u5177\u6743\u5a01\u6027\u548c\u5f71\u54cd\u529b\u7684\u5b66\u672f\u76db\u4f1a\u4e4b\u4e00\uff0c\u6c47\u805a\u4e86\u6765\u81ea\u4e16\u754c\u5404\u5730\u7684\u9876\u5c16\u4e13\u5bb6\u3001\u5b66\u8005\u548c\u4e34\u5e8a\u533b\u751f\uff0c\u56f4\u7ed5\u8840\u6db2\u5b66\u6700\u65b0\u7684\u57fa\u7840\u7814\u7a76\u3001\u4e34\u5e8a\u5b9e\u8df5\u548c\u521b\u65b0\u7597\u6cd5\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002<\/p>\n<p>\u4f5c\u4e3a&#8221;\u4e2d\u56fd\u58f0\u97f3&#8221;\u7684\u6770\u51fa\u4ee3\u8868\uff0c\u6bcf\u5e74\u7684ASH\u5e74\u4f1a\u4e0a\u90fd\u80fd\u770b\u5230\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u7684\u8eab\u5f71\uff0c\u672c\u5c4aASH\u5e74\u4f1a\uff0c\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u56e2\u961f\u518d\u5ea6\u51fa\u73b0\u5728\u73b0\u573a\uff0c\u901a\u8fc713\u9879\u7814\u7a76\u6210\u679c\u4e0e\u6765\u81ea\u5168\u7403\u8840\u6db2\u5b66\u4e13\u5bb6\u5b66\u8005\u5c55\u5f00\u5e7f\u6cdb\u4ea4\u6d41\u3001\u5b66\u4e60\u548c\u5206\u4eab\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnewswire.com\/media\/2579679\/image_844202_32411789.html\" target=\"_blank\" rel=\"noopener\"><\/a><\/p>\n<\/div>\n<p>\u8fd9\u4e9b\u7814\u7a76\u4ece\u591a\u7ef4\u5ea6\u5c55\u793a\u4e86\u8840\u6db2\u5b66\u9886\u57df\u7684\u524d\u6cbf\u8fdb\u5c55\uff0c\u6db5\u76d6\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u3001\u79fb\u690d\u7b56\u7565\u4f18\u5316\u3001\u7cbe\u51c6\u8bca\u65ad\u4ee5\u53ca\u57fa\u56e0\u7ec4\u5b66\u7b49\u591a\u4e2a\u65b9\u5411\uff0c\u5f97\u5230\u4e86\u4e0e\u4f1a\u4e13\u5bb6\u7684\u9ad8\u5ea6\u8bc4\u4ef7\uff0c\u6807\u5fd7\u7740\u56e2\u961f\u8840\u6db2\u75c5\u8bca\u7597\u5411\u66f4\u7cbe\u51c6\u3001\u66f4\u9ad8\u6548\u3001\u66f4\u4e2a\u6027\u5316\u7684\u65b9\u5411\u8fc8\u51fa\u91cd\u8981\u4e00\u6b65\u3002<\/p>\n<p>\u5927\u4f1a\u73b0\u573a\uff0c\u9488\u5bf9\u672c\u6b21\u5165\u9009\u7684&#8221;CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory\/Relapsed Peripheral T-Cell Lymphoma:Phase I Clinical Trial&#8221;\u7684\u7814\u7a76\u62a5\u544a\uff0c\u9646\u4f69\u534e\u9662\u957f\u63a5\u53d7\u4e86\u5a92\u4f53\u91c7\u8bbf\u3002<\/p>\n<p>\u8be5\u9879\u7814\u7a76\u521d\u6b65\u663e\u793a\u4e86CD7 CAR-T\u7597\u6cd5\u5bf9\u590d\u53d1\/\u96be\u6cbb\u6027PTCL\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u4e3a\u8fd9\u79cd\u9ad8\u5371\u80bf\u7624\u63d0\u4f9b\u4e86\u65b0\u6cbb\u7597\u9009\u62e9\u3002\u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u56e2\u961f\u5c06\u6301\u7eed\u63a8\u8fdbCD7 CAR-T\u6cbb\u7597\u7684\u57fa\u7840\u7814\u7a76\u4e0e\u4e34\u5e8a\u8f6c\u5316\uff0c\u79ef\u6781\u63a2\u7d22\u5176\u5728\u8054\u5408\u7597\u6cd5\u4e2d\u7684\u6f5c\u529b\uff0c\u5e76\u4e0d\u65ad\u5f00\u62d3\u65b0\u9776\u70b9\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u63d0\u4f9b\u66f4\u5168\u9762\u3001\u66f4\u9ad8\u6548\u7684\u6cbb\u7597\u9009\u62e9\u3002\u56e2\u961f\u7684\u76ee\u6807\u662f\u8ba9\u66f4\u591a\u60a3\u8005\u4ece\u8fd9\u4e00\u521b\u65b0\u7597\u6cd5\u4e2d\u83b7\u76ca\uff0c\u5171\u540c\u63a8\u52a8\u8840\u6db2\u80bf\u7624\u6cbb\u7597\u9886\u57df\u7684\u53d1\u5c55\u8fdb\u6b65\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnewswire.com\/media\/2579680\/image_844202_32412024.html\" target=\"_blank\" rel=\"noopener\"><\/a><\/p>\n<\/div>\n<p>\u672c\u5c4a\u5927\u4f1a\uff0c\u5899\u62a5\u5c55\u793a\u4e13\u533a\u4e5f\u662f\u6b64\u6b21\u5b66\u672f\u4ea4\u6d41\u7684\u7126\u70b9\u821e\u53f0\uff0c\u6765\u81ea\u5168\u7403\u7684\u6570\u767e\u7bc7\u79d1\u7814\u6210\u679c\u6c47\u805a\u4e8e\u6b64\uff0c\u805a\u7126\u5b66\u79d1\u524d\u6cbf\u95ee\u9898\u4e0e\u4e34\u5e8a\u6311\u6218\uff0c\u4e0e\u4f1a\u8005\u4eec\u5728\u5899\u62a5\u524d\u9a7b\u8db3\uff0c\u70ed\u70c8\u4ea4\u6d41\uff0c\u5206\u4eab\u5fc3\u5f97\u3002\u56e2\u961f\u4e0e\u6765\u81ea\u7f8e\u56fd\u3001\u6b27\u6d32\u53ca\u4e9a\u6d32\u7684\u9876\u7ea7\u8840\u6db2\u5b66\u4e2d\u5fc3\u4ee3\u8868\u8fdb\u884c\u9762\u5bf9\u9762\u7684\u4ea4\u6d41\u4e92\u52a8\uff0c\u6fc0\u53d1\u65b0\u7684\u7814\u7a76\u601d\u8def\uff0c\u63a2\u5bfb\u672a\u6765\u7684\u5408\u4f5c\u65b9\u5411\u3002<\/p>\n<p>ASH\u5e74\u4f1a\u4f5c\u4e3a\u5168\u7403\u8840\u6db2\u75c5\u9886\u57df\u7684\u9876\u5c16\u5b66\u672f\u76db\u4f1a\uff0c\u4e00\u76f4\u662f\u8840\u6db2\u5b66\u754c\u5173\u6ce8\u7684\u7126\u70b9\uff0c\u6bcf\u5e74\u6c47\u805a\u5168\u7403\u6700\u65b0\u7684\u79d1\u7814\u6210\u679c\u548c\u8bca\u7597\u8fdb\u5c55\u3002\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f\u5353\u8d8a\u7684\u79d1\u7814\u5b9e\u529b\u548c\u4e34\u5e8a\u6210\u5c31\uff0c\u8fde\u7eed\u591a\u5e74\u4ee5\u53e3\u5934\u62a5\u544a\u548c\u5899\u62a5\u5c55\u793a\u5165\u9009\uff0c\u8fd9\u4e0d\u4ec5\u4f53\u73b0\u4e86\u56e2\u961f\u5728\u56fd\u9645\u8840\u6db2\u5b66\u9886\u57df\u7684\u5f71\u54cd\u529b\uff0c\u66f4\u4e3a\u672a\u6765\u7684\u56fd\u9645\u5408\u4f5c\u548c\u4ea4\u6d41\u6253\u4e0b\u575a\u5b9e\u57fa\u7840\u3002<\/p>\n<p>\u672a\u6765\uff0c\u9646\u9053\u57f9\u533b\u9662\u5c06\u7ee7\u7eed\u79c9\u627f&#8221;\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3&#8221;\u7684\u5b97\u65e8\uff0c\u805a\u7126\u8840\u6db2\u75c5\u8bca\u7597\u7684\u524d\u6cbf\u95ee\u9898\uff0c\u4e0d\u65ad\u4f18\u5316\u8bca\u7597\u7b56\u7565\uff0c\u63a2\u7d22\u521b\u65b0\u7597\u6cd5\uff0c\u4e3a\u60a3\u8005\u5e26\u6765\u66f4\u52a0\u5b89\u5168\u3001\u9ad8\u6548\u7684\u8bca\u7597\u65b9\u6848\uff0c\u5e2e\u52a9\u66f4\u591a\u60a3\u8005\u5b9e\u73b0\u4e34\u5e8a\u6cbb\u6108\u548c\u957f\u671f\u751f\u5b58\u3002<\/p>\n<p class=\"prntac\">ASH 2024 \u6210\u679c\u4e00\u89c8<\/p>\n<p>\u6458\u8981\u53f7\uff1a1451<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aComprehensive Fusion Gene Landscape in B-cell Lymphoblastic Leukemia: Insights from Transcriptome Sequencing of 1015 Cases<\/p>\n<p>\u6458\u8981\u53f7\uff1a1467<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u9633\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aRecurrent Focal Mkks-SLX4IP Deletion in ETV6::RUNX1 and Ph\/Ph-like B-ALL<\/p>\n<p>\u6458\u8981\u53f7\uff1a2075<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9646\u4f69\u534e\uff1b\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/>\u9898\u76ee\uff1aCD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory\/Relapsed Peripheral T-CellLymphoma:Phase I Clinical Trial<\/p>\n<p>\u6458\u8981\u53f7\uff1a2148<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u738b\u78ca\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aDiagnosis and prognosis of aGVHD by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation<\/p>\n<p>\u6458\u8981\u53f7\uff1a3325<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u4efb\u96e8\u60a6\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u738b\u5dcd\uff1b\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aNGS-Based Immunoglobulin Gene Sequencing for Diagnosis and MRD Monitoring of Multiple Myeloma<\/p>\n<p>\u6458\u8981\u53f7\uff1a3492<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9b4f\u5fd7\u6770\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/>\u9898\u76ee\uff1aImproved Outcomes with Bu\/Cy+Melphalan and Bu\/Cy+Thiotepa Regimens in Haploidentical Hematopoietic Stem Cell Transplantation for Non-Down Syndrome Acute Megakaryoblastic Leukemia<\/p>\n<p>\u6458\u8981\u53f7\uff1a3546<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u5b59\u745e\u5a1f\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/>\u9898\u76ee\uff1aLong-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for 532 Patients with KMT2A-Rearranged Acute Leukemia\u00a0<\/p>\n<p>\u6458\u8981\u53f7\uff1a3595<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u4f73\u7426\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aHigh-Accurate Third-Generation Sequencing to Comprehensively Decipher BCR::ABL1 TKIs in-Cis Resistant Mutations<\/p>\n<p>\u6458\u8981\u53f7\uff1a4212<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aAdvances in B-ALL Diagnosis and ClassiCcation: A Comparative Analysis of Who-HAEM4R, Who- HAEM5 and ICC<\/p>\n<p>\u6458\u8981\u53f7\uff1a4323<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u5468\u6653\u82cf\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aInvestigation of Viral Gene Transcripts and Viral-Human Gene Fusions in Acute Leukemia Poly(A) RNA-seq Data<\/p>\n<p>\u6458\u8981\u53f7\uff1a4326<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f<br \/>\u9898\u76ee\uff1aExtensive Fusion Gene Profiling in Acute Myeloid Leukemia Revealed By Whole Transcriptome Sequencing of 1614 Cases<\/p>\n<p>\u6458\u8981\u53f7\uff1a4874<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u66fc\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u738b\u5349<br \/>\u9898\u76ee\uff1aClinical and Immunological Characteristics of Patients with CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation<\/p>\n<p>\u6458\u8981\u53f7\uff1a4934<br \/>\u7b2c\u4e00\u4f5c\u8005\uff1a\u66f9\u661f\u7389\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u9646\u4f69\u534e<br \/>\u9898\u76ee\uff1aA Long-Term Follow-up Retrospective Study of the Clinical Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation for Early T-Precursor Acute Lymphoblastic Leukemia and T-Lymphoblastic Lymphoma<\/p>\n<p>\u6ce8\uff1a\u4e0a\u8ff0\u7814\u7a76\u6210\u679c\u6309\u6458\u8981\u53f7\u6392\u5e8f<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<\/div>\n<p>SOURCE  \u9646\u9053\u57f9\u533b\u7597\u96c6\u56e2<\/p>","protected":false},"excerpt":{"rendered":"<p>\u5317\u4eac2024\u5e7412\u670812\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; 2024\u5e7412\u67086\u65e5\u81f312\u65e5\uff0c\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a\uff08ASH 2024\uff09\u5728\u7f8e\u56fd\u5723\u5730\u4e9a\u54e5\u76db\u5927\u53ec\u5f00\u3002\u672c\u6b21\u5927\u4f1a\u662f\u5168\u7403\u8840\u6db2\u5b66\u9886\u57df\u6700\u5177\u6743\u5a01\u6027\u548c\u5f71\u54cd\u529b\u7684\u5b66\u672f\u76db\u4f1a\u4e4b\u4e00\uff0c\u6c47\u805a\u4e86\u6765\u81ea\u4e16\u754c\u5404\u5730\u7684\u9876\u5c16\u4e13\u5bb6\u3001\u5b66\u8005\u548c\u4e34\u5e8a\u533b\u751f\uff0c\u56f4\u7ed5\u8840\u6db2\u5b66\u6700\u65b0\u7684\u57fa\u7840\u7814\u7a76\u3001\u4e34\u5e8a\u5b9e\u8df5\u548c\u521b\u65b0\u7597\u6cd5\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002 \u4f5c\u4e3a&#8221;\u4e2d\u56fd\u58f0\u97f3&#8221;\u7684\u6770\u51fa\u4ee3\u8868\uff0c\u6bcf\u5e74\u7684ASH\u5e74\u4f1a\u4e0a\u90fd\u80fd\u770b\u5230\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u7684\u8eab\u5f71\uff0c\u672c\u5c4aASH\u5e74\u4f1a\uff0c\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u56e2\u961f\u518d\u5ea6\u51fa\u73b0\u5728\u73b0\u573a\uff0c\u901a\u8fc713\u9879\u7814\u7a76\u6210\u679c\u4e0e\u6765\u81ea\u5168\u7403\u8840\u6db2\u5b66\u4e13\u5bb6\u5b66\u8005\u5c55\u5f00\u5e7f\u6cdb\u4ea4\u6d41\u3001\u5b66\u4e60\u548c\u5206\u4eab\u3002 \u8fd9\u4e9b\u7814\u7a76\u4ece\u591a\u7ef4\u5ea6\u5c55\u793a\u4e86\u8840\u6db2\u5b66\u9886\u57df\u7684\u524d\u6cbf\u8fdb\u5c55\uff0c\u6db5\u76d6\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u3001\u79fb\u690d\u7b56\u7565\u4f18\u5316\u3001\u7cbe\u51c6\u8bca\u65ad\u4ee5\u53ca\u57fa\u56e0\u7ec4\u5b66\u7b49\u591a\u4e2a\u65b9\u5411\uff0c\u5f97\u5230\u4e86\u4e0e\u4f1a\u4e13\u5bb6\u7684\u9ad8\u5ea6\u8bc4\u4ef7\uff0c\u6807\u5fd7\u7740\u56e2\u961f\u8840\u6db2\u75c5\u8bca\u7597\u5411\u66f4\u7cbe\u51c6\u3001\u66f4\u9ad8\u6548\u3001\u66f4\u4e2a\u6027\u5316\u7684\u65b9\u5411\u8fc8\u51fa\u91cd\u8981\u4e00\u6b65\u3002 \u5927\u4f1a\u73b0\u573a\uff0c\u9488\u5bf9\u672c\u6b21\u5165\u9009\u7684&#8221;CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory\/Relapsed Peripheral T-Cell Lymphoma:Phase I Clinical Trial&#8221;\u7684\u7814\u7a76\u62a5\u544a\uff0c\u9646\u4f69\u534e\u9662\u957f\u63a5\u53d7\u4e86\u5a92\u4f53\u91c7\u8bbf\u3002 \u8be5\u9879\u7814\u7a76\u521d\u6b65\u663e\u793a\u4e86CD7 CAR-T\u7597\u6cd5\u5bf9\u590d\u53d1\/\u96be\u6cbb\u6027PTCL\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u4e3a\u8fd9\u79cd\u9ad8\u5371\u80bf\u7624\u63d0\u4f9b\u4e86\u65b0\u6cbb\u7597\u9009\u62e9\u3002\u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u56e2\u961f\u5c06\u6301\u7eed\u63a8\u8fdbCD7 CAR-T\u6cbb\u7597\u7684\u57fa\u7840\u7814\u7a76\u4e0e\u4e34\u5e8a\u8f6c\u5316\uff0c\u79ef\u6781\u63a2\u7d22\u5176\u5728\u8054\u5408\u7597\u6cd5\u4e2d\u7684\u6f5c\u529b\uff0c\u5e76\u4e0d\u65ad\u5f00\u62d3\u65b0\u9776\u70b9\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u63d0\u4f9b\u66f4\u5168\u9762\u3001\u66f4\u9ad8\u6548\u7684\u6cbb\u7597\u9009\u62e9\u3002\u56e2\u961f\u7684\u76ee\u6807\u662f\u8ba9\u66f4\u591a\u60a3\u8005\u4ece\u8fd9\u4e00\u521b\u65b0\u7597\u6cd5\u4e2d\u83b7\u76ca\uff0c\u5171\u540c\u63a8\u52a8\u8840\u6db2\u80bf\u7624\u6cbb\u7597\u9886\u57df\u7684\u53d1\u5c55\u8fdb\u6b65\u3002 \u672c\u5c4a\u5927\u4f1a\uff0c\u5899\u62a5\u5c55\u793a\u4e13\u533a\u4e5f\u662f\u6b64\u6b21\u5b66\u672f\u4ea4\u6d41\u7684\u7126\u70b9\u821e\u53f0\uff0c\u6765\u81ea\u5168\u7403\u7684\u6570\u767e\u7bc7\u79d1\u7814\u6210\u679c\u6c47\u805a\u4e8e\u6b64\uff0c\u805a\u7126\u5b66\u79d1\u524d\u6cbf\u95ee\u9898\u4e0e\u4e34\u5e8a\u6311\u6218\uff0c\u4e0e\u4f1a\u8005\u4eec\u5728\u5899\u62a5\u524d\u9a7b\u8db3\uff0c\u70ed\u70c8\u4ea4\u6d41\uff0c\u5206\u4eab\u5fc3\u5f97\u3002\u56e2\u961f\u4e0e\u6765\u81ea\u7f8e\u56fd\u3001\u6b27\u6d32\u53ca\u4e9a\u6d32\u7684\u9876\u7ea7\u8840\u6db2\u5b66\u4e2d\u5fc3\u4ee3\u8868\u8fdb\u884c\u9762\u5bf9\u9762\u7684\u4ea4\u6d41\u4e92\u52a8\uff0c\u6fc0\u53d1\u65b0\u7684\u7814\u7a76\u601d\u8def\uff0c\u63a2\u5bfb\u672a\u6765\u7684\u5408\u4f5c\u65b9\u5411\u3002 ASH\u5e74\u4f1a\u4f5c\u4e3a\u5168\u7403\u8840\u6db2\u75c5\u9886\u57df\u7684\u9876\u5c16\u5b66\u672f\u76db\u4f1a\uff0c\u4e00\u76f4\u662f\u8840\u6db2\u5b66\u754c\u5173\u6ce8\u7684\u7126\u70b9\uff0c\u6bcf\u5e74\u6c47\u805a\u5168\u7403\u6700\u65b0\u7684\u79d1\u7814\u6210\u679c\u548c\u8bca\u7597\u8fdb\u5c55\u3002\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f\u5353\u8d8a\u7684\u79d1\u7814\u5b9e\u529b\u548c\u4e34\u5e8a\u6210\u5c31\uff0c\u8fde\u7eed\u591a\u5e74\u4ee5\u53e3\u5934\u62a5\u544a\u548c\u5899\u62a5\u5c55\u793a\u5165\u9009\uff0c\u8fd9\u4e0d\u4ec5\u4f53\u73b0\u4e86\u56e2\u961f\u5728\u56fd\u9645\u8840\u6db2\u5b66\u9886\u57df\u7684\u5f71\u54cd\u529b\uff0c\u66f4\u4e3a\u672a\u6765\u7684\u56fd\u9645\u5408\u4f5c\u548c\u4ea4\u6d41\u6253\u4e0b\u575a\u5b9e\u57fa\u7840\u3002 \u672a\u6765\uff0c\u9646\u9053\u57f9\u533b\u9662\u5c06\u7ee7\u7eed\u79c9\u627f&#8221;\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3&#8221;\u7684\u5b97\u65e8\uff0c\u805a\u7126\u8840\u6db2\u75c5\u8bca\u7597\u7684\u524d\u6cbf\u95ee\u9898\uff0c\u4e0d\u65ad\u4f18\u5316\u8bca\u7597\u7b56\u7565\uff0c\u63a2\u7d22\u521b\u65b0\u7597\u6cd5\uff0c\u4e3a\u60a3\u8005\u5e26\u6765\u66f4\u52a0\u5b89\u5168\u3001\u9ad8\u6548\u7684\u8bca\u7597\u65b9\u6848\uff0c\u5e2e\u52a9\u66f4\u591a\u60a3\u8005\u5b9e\u73b0\u4e34\u5e8a\u6cbb\u6108\u548c\u957f\u671f\u751f\u5b58\u3002 ASH 2024 \u6210\u679c\u4e00\u89c8 \u6458\u8981\u53f7\uff1a1451\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f\u9898\u76ee\uff1aComprehensive Fusion Gene Landscape in B-cell Lymphoblastic Leukemia: Insights from Transcriptome Sequencing of 1015 Cases \u6458\u8981\u53f7\uff1a1467\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u9633\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f\u9898\u76ee\uff1aRecurrent Focal Mkks-SLX4IP Deletion in ETV6::RUNX1 [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":5568,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-5567","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH) - Money Compass CN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/moneycompass.com.my\/cn\/\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH) - Money Compass CN\" \/>\n<meta property=\"og:description\" content=\"\u5317\u4eac2024\u5e7412\u670812\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; 2024\u5e7412\u67086\u65e5\u81f312\u65e5\uff0c\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a\uff08ASH 2024\uff09\u5728\u7f8e\u56fd\u5723\u5730\u4e9a\u54e5\u76db\u5927\u53ec\u5f00\u3002\u672c\u6b21\u5927\u4f1a\u662f\u5168\u7403\u8840\u6db2\u5b66\u9886\u57df\u6700\u5177\u6743\u5a01\u6027\u548c\u5f71\u54cd\u529b\u7684\u5b66\u672f\u76db\u4f1a\u4e4b\u4e00\uff0c\u6c47\u805a\u4e86\u6765\u81ea\u4e16\u754c\u5404\u5730\u7684\u9876\u5c16\u4e13\u5bb6\u3001\u5b66\u8005\u548c\u4e34\u5e8a\u533b\u751f\uff0c\u56f4\u7ed5\u8840\u6db2\u5b66\u6700\u65b0\u7684\u57fa\u7840\u7814\u7a76\u3001\u4e34\u5e8a\u5b9e\u8df5\u548c\u521b\u65b0\u7597\u6cd5\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002 \u4f5c\u4e3a&#8221;\u4e2d\u56fd\u58f0\u97f3&#8221;\u7684\u6770\u51fa\u4ee3\u8868\uff0c\u6bcf\u5e74\u7684ASH\u5e74\u4f1a\u4e0a\u90fd\u80fd\u770b\u5230\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u7684\u8eab\u5f71\uff0c\u672c\u5c4aASH\u5e74\u4f1a\uff0c\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u56e2\u961f\u518d\u5ea6\u51fa\u73b0\u5728\u73b0\u573a\uff0c\u901a\u8fc713\u9879\u7814\u7a76\u6210\u679c\u4e0e\u6765\u81ea\u5168\u7403\u8840\u6db2\u5b66\u4e13\u5bb6\u5b66\u8005\u5c55\u5f00\u5e7f\u6cdb\u4ea4\u6d41\u3001\u5b66\u4e60\u548c\u5206\u4eab\u3002 \u8fd9\u4e9b\u7814\u7a76\u4ece\u591a\u7ef4\u5ea6\u5c55\u793a\u4e86\u8840\u6db2\u5b66\u9886\u57df\u7684\u524d\u6cbf\u8fdb\u5c55\uff0c\u6db5\u76d6\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u3001\u79fb\u690d\u7b56\u7565\u4f18\u5316\u3001\u7cbe\u51c6\u8bca\u65ad\u4ee5\u53ca\u57fa\u56e0\u7ec4\u5b66\u7b49\u591a\u4e2a\u65b9\u5411\uff0c\u5f97\u5230\u4e86\u4e0e\u4f1a\u4e13\u5bb6\u7684\u9ad8\u5ea6\u8bc4\u4ef7\uff0c\u6807\u5fd7\u7740\u56e2\u961f\u8840\u6db2\u75c5\u8bca\u7597\u5411\u66f4\u7cbe\u51c6\u3001\u66f4\u9ad8\u6548\u3001\u66f4\u4e2a\u6027\u5316\u7684\u65b9\u5411\u8fc8\u51fa\u91cd\u8981\u4e00\u6b65\u3002 \u5927\u4f1a\u73b0\u573a\uff0c\u9488\u5bf9\u672c\u6b21\u5165\u9009\u7684&#8221;CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory\/Relapsed Peripheral T-Cell Lymphoma:Phase I Clinical Trial&#8221;\u7684\u7814\u7a76\u62a5\u544a\uff0c\u9646\u4f69\u534e\u9662\u957f\u63a5\u53d7\u4e86\u5a92\u4f53\u91c7\u8bbf\u3002 \u8be5\u9879\u7814\u7a76\u521d\u6b65\u663e\u793a\u4e86CD7 CAR-T\u7597\u6cd5\u5bf9\u590d\u53d1\/\u96be\u6cbb\u6027PTCL\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u4e3a\u8fd9\u79cd\u9ad8\u5371\u80bf\u7624\u63d0\u4f9b\u4e86\u65b0\u6cbb\u7597\u9009\u62e9\u3002\u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u56e2\u961f\u5c06\u6301\u7eed\u63a8\u8fdbCD7 CAR-T\u6cbb\u7597\u7684\u57fa\u7840\u7814\u7a76\u4e0e\u4e34\u5e8a\u8f6c\u5316\uff0c\u79ef\u6781\u63a2\u7d22\u5176\u5728\u8054\u5408\u7597\u6cd5\u4e2d\u7684\u6f5c\u529b\uff0c\u5e76\u4e0d\u65ad\u5f00\u62d3\u65b0\u9776\u70b9\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u63d0\u4f9b\u66f4\u5168\u9762\u3001\u66f4\u9ad8\u6548\u7684\u6cbb\u7597\u9009\u62e9\u3002\u56e2\u961f\u7684\u76ee\u6807\u662f\u8ba9\u66f4\u591a\u60a3\u8005\u4ece\u8fd9\u4e00\u521b\u65b0\u7597\u6cd5\u4e2d\u83b7\u76ca\uff0c\u5171\u540c\u63a8\u52a8\u8840\u6db2\u80bf\u7624\u6cbb\u7597\u9886\u57df\u7684\u53d1\u5c55\u8fdb\u6b65\u3002 \u672c\u5c4a\u5927\u4f1a\uff0c\u5899\u62a5\u5c55\u793a\u4e13\u533a\u4e5f\u662f\u6b64\u6b21\u5b66\u672f\u4ea4\u6d41\u7684\u7126\u70b9\u821e\u53f0\uff0c\u6765\u81ea\u5168\u7403\u7684\u6570\u767e\u7bc7\u79d1\u7814\u6210\u679c\u6c47\u805a\u4e8e\u6b64\uff0c\u805a\u7126\u5b66\u79d1\u524d\u6cbf\u95ee\u9898\u4e0e\u4e34\u5e8a\u6311\u6218\uff0c\u4e0e\u4f1a\u8005\u4eec\u5728\u5899\u62a5\u524d\u9a7b\u8db3\uff0c\u70ed\u70c8\u4ea4\u6d41\uff0c\u5206\u4eab\u5fc3\u5f97\u3002\u56e2\u961f\u4e0e\u6765\u81ea\u7f8e\u56fd\u3001\u6b27\u6d32\u53ca\u4e9a\u6d32\u7684\u9876\u7ea7\u8840\u6db2\u5b66\u4e2d\u5fc3\u4ee3\u8868\u8fdb\u884c\u9762\u5bf9\u9762\u7684\u4ea4\u6d41\u4e92\u52a8\uff0c\u6fc0\u53d1\u65b0\u7684\u7814\u7a76\u601d\u8def\uff0c\u63a2\u5bfb\u672a\u6765\u7684\u5408\u4f5c\u65b9\u5411\u3002 ASH\u5e74\u4f1a\u4f5c\u4e3a\u5168\u7403\u8840\u6db2\u75c5\u9886\u57df\u7684\u9876\u5c16\u5b66\u672f\u76db\u4f1a\uff0c\u4e00\u76f4\u662f\u8840\u6db2\u5b66\u754c\u5173\u6ce8\u7684\u7126\u70b9\uff0c\u6bcf\u5e74\u6c47\u805a\u5168\u7403\u6700\u65b0\u7684\u79d1\u7814\u6210\u679c\u548c\u8bca\u7597\u8fdb\u5c55\u3002\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f\u5353\u8d8a\u7684\u79d1\u7814\u5b9e\u529b\u548c\u4e34\u5e8a\u6210\u5c31\uff0c\u8fde\u7eed\u591a\u5e74\u4ee5\u53e3\u5934\u62a5\u544a\u548c\u5899\u62a5\u5c55\u793a\u5165\u9009\uff0c\u8fd9\u4e0d\u4ec5\u4f53\u73b0\u4e86\u56e2\u961f\u5728\u56fd\u9645\u8840\u6db2\u5b66\u9886\u57df\u7684\u5f71\u54cd\u529b\uff0c\u66f4\u4e3a\u672a\u6765\u7684\u56fd\u9645\u5408\u4f5c\u548c\u4ea4\u6d41\u6253\u4e0b\u575a\u5b9e\u57fa\u7840\u3002 \u672a\u6765\uff0c\u9646\u9053\u57f9\u533b\u9662\u5c06\u7ee7\u7eed\u79c9\u627f&#8221;\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3&#8221;\u7684\u5b97\u65e8\uff0c\u805a\u7126\u8840\u6db2\u75c5\u8bca\u7597\u7684\u524d\u6cbf\u95ee\u9898\uff0c\u4e0d\u65ad\u4f18\u5316\u8bca\u7597\u7b56\u7565\uff0c\u63a2\u7d22\u521b\u65b0\u7597\u6cd5\uff0c\u4e3a\u60a3\u8005\u5e26\u6765\u66f4\u52a0\u5b89\u5168\u3001\u9ad8\u6548\u7684\u8bca\u7597\u65b9\u6848\uff0c\u5e2e\u52a9\u66f4\u591a\u60a3\u8005\u5b9e\u73b0\u4e34\u5e8a\u6cbb\u6108\u548c\u957f\u671f\u751f\u5b58\u3002 ASH 2024 \u6210\u679c\u4e00\u89c8 \u6458\u8981\u53f7\uff1a1451\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f\u9898\u76ee\uff1aComprehensive Fusion Gene Landscape in B-cell Lymphoblastic Leukemia: Insights from Transcriptome Sequencing of 1015 Cases \u6458\u8981\u53f7\uff1a1467\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u9633\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f\u9898\u76ee\uff1aRecurrent Focal Mkks-SLX4IP Deletion in ETV6::RUNX1 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/moneycompass.com.my\/cn\/\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\/\" \/>\n<meta property=\"og:site_name\" content=\"Money Compass CN\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-12T10:25:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"144\" \/>\n\t<meta property=\"og:image:height\" content=\"98\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/\",\"name\":\"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH) - Money Compass CN\",\"isPartOf\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg\",\"datePublished\":\"2024-12-12T10:25:00+00:00\",\"dateModified\":\"2024-12-12T10:25:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#primaryimage\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg\",\"contentUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg\",\"width\":144,\"height\":98},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/moneycompass.com.my\/cn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/\",\"name\":\"Money Compass CN\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH) - Money Compass CN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/moneycompass.com.my\/cn\/\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\/","og_locale":"en_US","og_type":"article","og_title":"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH) - Money Compass CN","og_description":"\u5317\u4eac2024\u5e7412\u670812\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; 2024\u5e7412\u67086\u65e5\u81f312\u65e5\uff0c\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a\uff08ASH 2024\uff09\u5728\u7f8e\u56fd\u5723\u5730\u4e9a\u54e5\u76db\u5927\u53ec\u5f00\u3002\u672c\u6b21\u5927\u4f1a\u662f\u5168\u7403\u8840\u6db2\u5b66\u9886\u57df\u6700\u5177\u6743\u5a01\u6027\u548c\u5f71\u54cd\u529b\u7684\u5b66\u672f\u76db\u4f1a\u4e4b\u4e00\uff0c\u6c47\u805a\u4e86\u6765\u81ea\u4e16\u754c\u5404\u5730\u7684\u9876\u5c16\u4e13\u5bb6\u3001\u5b66\u8005\u548c\u4e34\u5e8a\u533b\u751f\uff0c\u56f4\u7ed5\u8840\u6db2\u5b66\u6700\u65b0\u7684\u57fa\u7840\u7814\u7a76\u3001\u4e34\u5e8a\u5b9e\u8df5\u548c\u521b\u65b0\u7597\u6cd5\u5c55\u5f00\u6df1\u5165\u63a2\u8ba8\u3002 \u4f5c\u4e3a&#8221;\u4e2d\u56fd\u58f0\u97f3&#8221;\u7684\u6770\u51fa\u4ee3\u8868\uff0c\u6bcf\u5e74\u7684ASH\u5e74\u4f1a\u4e0a\u90fd\u80fd\u770b\u5230\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u7684\u8eab\u5f71\uff0c\u672c\u5c4aASH\u5e74\u4f1a\uff0c\u56e2\u961f\u5b66\u672f\u5e26\u5934\u4eba\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u56e2\u961f\u518d\u5ea6\u51fa\u73b0\u5728\u73b0\u573a\uff0c\u901a\u8fc713\u9879\u7814\u7a76\u6210\u679c\u4e0e\u6765\u81ea\u5168\u7403\u8840\u6db2\u5b66\u4e13\u5bb6\u5b66\u8005\u5c55\u5f00\u5e7f\u6cdb\u4ea4\u6d41\u3001\u5b66\u4e60\u548c\u5206\u4eab\u3002 \u8fd9\u4e9b\u7814\u7a76\u4ece\u591a\u7ef4\u5ea6\u5c55\u793a\u4e86\u8840\u6db2\u5b66\u9886\u57df\u7684\u524d\u6cbf\u8fdb\u5c55\uff0c\u6db5\u76d6\u7ec6\u80de\u514d\u75ab\u6cbb\u7597\u3001\u79fb\u690d\u7b56\u7565\u4f18\u5316\u3001\u7cbe\u51c6\u8bca\u65ad\u4ee5\u53ca\u57fa\u56e0\u7ec4\u5b66\u7b49\u591a\u4e2a\u65b9\u5411\uff0c\u5f97\u5230\u4e86\u4e0e\u4f1a\u4e13\u5bb6\u7684\u9ad8\u5ea6\u8bc4\u4ef7\uff0c\u6807\u5fd7\u7740\u56e2\u961f\u8840\u6db2\u75c5\u8bca\u7597\u5411\u66f4\u7cbe\u51c6\u3001\u66f4\u9ad8\u6548\u3001\u66f4\u4e2a\u6027\u5316\u7684\u65b9\u5411\u8fc8\u51fa\u91cd\u8981\u4e00\u6b65\u3002 \u5927\u4f1a\u73b0\u573a\uff0c\u9488\u5bf9\u672c\u6b21\u5165\u9009\u7684&#8221;CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory\/Relapsed Peripheral T-Cell Lymphoma:Phase I Clinical Trial&#8221;\u7684\u7814\u7a76\u62a5\u544a\uff0c\u9646\u4f69\u534e\u9662\u957f\u63a5\u53d7\u4e86\u5a92\u4f53\u91c7\u8bbf\u3002 \u8be5\u9879\u7814\u7a76\u521d\u6b65\u663e\u793a\u4e86CD7 CAR-T\u7597\u6cd5\u5bf9\u590d\u53d1\/\u96be\u6cbb\u6027PTCL\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u4e3a\u8fd9\u79cd\u9ad8\u5371\u80bf\u7624\u63d0\u4f9b\u4e86\u65b0\u6cbb\u7597\u9009\u62e9\u3002\u9646\u4f69\u534e\u9662\u957f\u8868\u793a\uff0c\u56e2\u961f\u5c06\u6301\u7eed\u63a8\u8fdbCD7 CAR-T\u6cbb\u7597\u7684\u57fa\u7840\u7814\u7a76\u4e0e\u4e34\u5e8a\u8f6c\u5316\uff0c\u79ef\u6781\u63a2\u7d22\u5176\u5728\u8054\u5408\u7597\u6cd5\u4e2d\u7684\u6f5c\u529b\uff0c\u5e76\u4e0d\u65ad\u5f00\u62d3\u65b0\u9776\u70b9\uff0c\u4e3a\u8840\u6db2\u80bf\u7624\u60a3\u8005\u63d0\u4f9b\u66f4\u5168\u9762\u3001\u66f4\u9ad8\u6548\u7684\u6cbb\u7597\u9009\u62e9\u3002\u56e2\u961f\u7684\u76ee\u6807\u662f\u8ba9\u66f4\u591a\u60a3\u8005\u4ece\u8fd9\u4e00\u521b\u65b0\u7597\u6cd5\u4e2d\u83b7\u76ca\uff0c\u5171\u540c\u63a8\u52a8\u8840\u6db2\u80bf\u7624\u6cbb\u7597\u9886\u57df\u7684\u53d1\u5c55\u8fdb\u6b65\u3002 \u672c\u5c4a\u5927\u4f1a\uff0c\u5899\u62a5\u5c55\u793a\u4e13\u533a\u4e5f\u662f\u6b64\u6b21\u5b66\u672f\u4ea4\u6d41\u7684\u7126\u70b9\u821e\u53f0\uff0c\u6765\u81ea\u5168\u7403\u7684\u6570\u767e\u7bc7\u79d1\u7814\u6210\u679c\u6c47\u805a\u4e8e\u6b64\uff0c\u805a\u7126\u5b66\u79d1\u524d\u6cbf\u95ee\u9898\u4e0e\u4e34\u5e8a\u6311\u6218\uff0c\u4e0e\u4f1a\u8005\u4eec\u5728\u5899\u62a5\u524d\u9a7b\u8db3\uff0c\u70ed\u70c8\u4ea4\u6d41\uff0c\u5206\u4eab\u5fc3\u5f97\u3002\u56e2\u961f\u4e0e\u6765\u81ea\u7f8e\u56fd\u3001\u6b27\u6d32\u53ca\u4e9a\u6d32\u7684\u9876\u7ea7\u8840\u6db2\u5b66\u4e2d\u5fc3\u4ee3\u8868\u8fdb\u884c\u9762\u5bf9\u9762\u7684\u4ea4\u6d41\u4e92\u52a8\uff0c\u6fc0\u53d1\u65b0\u7684\u7814\u7a76\u601d\u8def\uff0c\u63a2\u5bfb\u672a\u6765\u7684\u5408\u4f5c\u65b9\u5411\u3002 ASH\u5e74\u4f1a\u4f5c\u4e3a\u5168\u7403\u8840\u6db2\u75c5\u9886\u57df\u7684\u9876\u5c16\u5b66\u672f\u76db\u4f1a\uff0c\u4e00\u76f4\u662f\u8840\u6db2\u5b66\u754c\u5173\u6ce8\u7684\u7126\u70b9\uff0c\u6bcf\u5e74\u6c47\u805a\u5168\u7403\u6700\u65b0\u7684\u79d1\u7814\u6210\u679c\u548c\u8bca\u7597\u8fdb\u5c55\u3002\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u51ed\u501f\u5353\u8d8a\u7684\u79d1\u7814\u5b9e\u529b\u548c\u4e34\u5e8a\u6210\u5c31\uff0c\u8fde\u7eed\u591a\u5e74\u4ee5\u53e3\u5934\u62a5\u544a\u548c\u5899\u62a5\u5c55\u793a\u5165\u9009\uff0c\u8fd9\u4e0d\u4ec5\u4f53\u73b0\u4e86\u56e2\u961f\u5728\u56fd\u9645\u8840\u6db2\u5b66\u9886\u57df\u7684\u5f71\u54cd\u529b\uff0c\u66f4\u4e3a\u672a\u6765\u7684\u56fd\u9645\u5408\u4f5c\u548c\u4ea4\u6d41\u6253\u4e0b\u575a\u5b9e\u57fa\u7840\u3002 \u672a\u6765\uff0c\u9646\u9053\u57f9\u533b\u9662\u5c06\u7ee7\u7eed\u79c9\u627f&#8221;\u4ee5\u60a3\u8005\u4e3a\u4e2d\u5fc3&#8221;\u7684\u5b97\u65e8\uff0c\u805a\u7126\u8840\u6db2\u75c5\u8bca\u7597\u7684\u524d\u6cbf\u95ee\u9898\uff0c\u4e0d\u65ad\u4f18\u5316\u8bca\u7597\u7b56\u7565\uff0c\u63a2\u7d22\u521b\u65b0\u7597\u6cd5\uff0c\u4e3a\u60a3\u8005\u5e26\u6765\u66f4\u52a0\u5b89\u5168\u3001\u9ad8\u6548\u7684\u8bca\u7597\u65b9\u6848\uff0c\u5e2e\u52a9\u66f4\u591a\u60a3\u8005\u5b9e\u73b0\u4e34\u5e8a\u6cbb\u6108\u548c\u957f\u671f\u751f\u5b58\u3002 ASH 2024 \u6210\u679c\u4e00\u89c8 \u6458\u8981\u53f7\uff1a1451\u7b2c\u4e00\u4f5c\u8005\uff1a\u9648\u96ea\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f\u9898\u76ee\uff1aComprehensive Fusion Gene Landscape in B-cell Lymphoblastic Leukemia: Insights from Transcriptome Sequencing of 1015 Cases \u6458\u8981\u53f7\uff1a1467\u7b2c\u4e00\u4f5c\u8005\uff1a\u5f20\u9633\uff0c\u901a\u8baf\u4f5c\u8005\uff1a\u5218\u7ea2\u661f\u9898\u76ee\uff1aRecurrent Focal Mkks-SLX4IP Deletion in ETV6::RUNX1 [&hellip;]","og_url":"https:\/\/moneycompass.com.my\/cn\/\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\/","og_site_name":"Money Compass CN","article_published_time":"2024-12-12T10:25:00+00:00","og_image":[{"width":144,"height":98,"url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/","url":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/","name":"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH) - Money Compass CN","isPartOf":{"@id":"https:\/\/moneycompass.com.my\/cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#primaryimage"},"image":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#primaryimage"},"thumbnailUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg","datePublished":"2024-12-12T10:25:00+00:00","dateModified":"2024-12-12T10:25:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#primaryimage","url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg","contentUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2024\/12\/image_844202_32411789-ZEQaol.jpeg","width":144,"height":98},{"@type":"BreadcrumbList","@id":"https:\/\/moneycompass.com.my\/cn\/%e9%99%86%e4%bd%a9%e5%8d%8e%e9%99%a2%e9%95%bf%e5%b8%a6%e9%a2%86%e9%99%86%e9%81%93%e5%9f%b9%e5%8c%bb%e5%ad%a6%e5%9b%a2%e9%98%9f%e5%8f%82%e5%8a%a0%e7%ac%ac66%e5%b1%8a%e7%be%8e%e5%9b%bd%e8%a1%80%e6%b6%b2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/moneycompass.com.my\/cn\/"},{"@type":"ListItem","position":2,"name":"\u9646\u4f69\u534e\u9662\u957f\u5e26\u9886\u9646\u9053\u57f9\u533b\u5b66\u56e2\u961f\u53c2\u52a0\u7b2c66\u5c4a\u7f8e\u56fd\u8840\u6db2\u5b66\u4f1a\u5e74\u4f1a(ASH)"}]},{"@type":"WebSite","@id":"https:\/\/moneycompass.com.my\/cn\/#website","url":"https:\/\/moneycompass.com.my\/cn\/","name":"Money Compass CN","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/5567"}],"collection":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/comments?post=5567"}],"version-history":[{"count":0,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/5567\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media\/5568"}],"wp:attachment":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media?parent=5567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/categories?post=5567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/tags?post=5567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}